279 related articles for article (PubMed ID: 26891946)
1. Brivaracetam in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus.
Strzelczyk A; Klein KM; Willems LM; Rosenow F; Bauer S
Expert Rev Clin Pharmacol; 2016; 9(5):637-45. PubMed ID: 26891946
[TBL] [Abstract][Full Text] [Related]
2. [Brivaracetam for add-on treatment in focal epilepsy].
Strzelczyk A; Steinig I; Klein KM; Willems LM; Knake S; Rosenow F; Bauer S
Nervenarzt; 2016 Oct; 87(10):1086-1093. PubMed ID: 27389600
[TBL] [Abstract][Full Text] [Related]
3. Brivaracetam: new compound approved for the treatment of epilepsy.
Zaccara G
Drugs Today (Barc); 2016 Apr; 52(4):219-27. PubMed ID: 27252986
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial.
Kwan P; Trinka E; Van Paesschen W; Rektor I; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):38-46. PubMed ID: 24116853
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in the pharmacotherapy of epilepsy: brivaracetam and perampanel as broad-spectrum antiseizure drugs for the treatment of epilepsies and status epilepticus.
Willems LM; Bauer S; Rosenow F; Strzelczyk A
Expert Opin Pharmacother; 2019 Oct; 20(14):1755-1765. PubMed ID: 31264486
[No Abstract] [Full Text] [Related]
6. Postmarketing experience with brivaracetam in the treatment of epilepsies: A multicenter cohort study from Germany.
Steinig I; von Podewils F; Möddel G; Bauer S; Klein KM; Paule E; Reif PS; Willems LM; Zöllner JP; Kunz R; Runge U; Kurlemann G; Schubert-Bast S; Rosenow F; Strzelczyk A
Epilepsia; 2017 Jul; 58(7):1208-1216. PubMed ID: 28480518
[TBL] [Abstract][Full Text] [Related]
7. Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial.
Ryvlin P; Werhahn KJ; Blaszczyk B; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):47-56. PubMed ID: 24256083
[TBL] [Abstract][Full Text] [Related]
8. Perampanel in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus.
Strzelczyk A; Willems LM; Willig S; Rosenow F; Bauer S
Expert Rev Clin Pharmacol; 2015; 8(6):733-40. PubMed ID: 26436331
[TBL] [Abstract][Full Text] [Related]
9. Brivaracetam: An Adjunctive Treatment for Partial-Onset Seizures.
Kappes JA; Hayes WJ; Strain JD; Farver DK
J Clin Pharmacol; 2017 Jul; 57(7):811-817. PubMed ID: 28394442
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of brivaracetam: a new drug to treat epilepsy.
Milovanović JR; Janković SM; Pejčić A; Milosavljević M; Opančina V; Radonjić V; Protrka Z; Kostić M
Expert Opin Pharmacother; 2017 Sep; 18(13):1381-1389. PubMed ID: 28737479
[TBL] [Abstract][Full Text] [Related]
11. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
[TBL] [Abstract][Full Text] [Related]
12. Adjunctive brivaracetam in focal and generalized epilepsies: A single-center open-label prospective study in patients with psychiatric comorbidities and intellectual disability.
Foo EC; Geldard J; Peacey C; Wright E; Eltayeb K; Maguire M
Epilepsy Behav; 2019 Oct; 99():106505. PubMed ID: 31493736
[TBL] [Abstract][Full Text] [Related]
13. Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures.
Mumoli L; Palleria C; Gasparini S; Citraro R; Labate A; Ferlazzo E; Gambardella A; De Sarro G; Russo E
Drug Des Devel Ther; 2015; 9():5719-25. PubMed ID: 26543353
[TBL] [Abstract][Full Text] [Related]
14. Use of brivaracetam in genetic generalized epilepsies and for acute, intravenous treatment of absence status epilepticus.
Strzelczyk A; Kay L; Bauer S; Immisch I; Klein KM; Knake S; Kowski A; Kunz R; Kurlemann G; Langenbruch L; Möddel G; Müller-Schlüter K; Reif PS; Schubert-Bast S; Steinhoff BJ; Steinig I; Willems LM; von Podewils F; Rosenow F
Epilepsia; 2018 Aug; 59(8):1549-1556. PubMed ID: 29943451
[TBL] [Abstract][Full Text] [Related]
15. Brivaracetam for the treatment of epilepsy.
Schulze-Bonhage A
Expert Opin Pharmacother; 2011 Aug; 12(12):1959-66. PubMed ID: 21682662
[TBL] [Abstract][Full Text] [Related]
16. New developments in the management of partial-onset epilepsy: role of brivaracetam.
Coppola G; Iapadre G; Operto FF; Verrotti A
Drug Des Devel Ther; 2017; 11():643-657. PubMed ID: 28293101
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures.
Klein P; Schiemann J; Sperling MR; Whitesides J; Liang W; Stalvey T; Brandt C; Kwan P
Epilepsia; 2015 Dec; 56(12):1890-8. PubMed ID: 26471380
[TBL] [Abstract][Full Text] [Related]
18. Safety and tolerability of adjunctive brivaracetam in epilepsy: In-depth pooled analysis.
Brandt C; Klein P; Badalamenti V; Gasalla T; Whitesides J
Epilepsy Behav; 2020 Feb; 103(Pt A):106864. PubMed ID: 31937513
[TBL] [Abstract][Full Text] [Related]
19. Treatment with brivaracetam in children - The experience of a pediatric epilepsy center.
Nissenkorn A; Tzadok M; Bar-Yosef O; Ben-Zeev B
Epilepsy Behav; 2019 Dec; 101(Pt A):106541. PubMed ID: 31698260
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive brivaracetam for patients with refractory partial seizures: A meta-analysis of randomized placebo-controlled trials.
Ma J; Huang S; You C
Epilepsy Res; 2015 Aug; 114():59-65. PubMed ID: 26088886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
